Alternates of the Medicinal and Aromatic Plants for Future Industrial Demand, Development, and Conceivable Conservation

Authors

  • C S Rana Principal Scientist at Pharmacognosy Lab, Department of Bio-resources, Dabur Research and Development Centre, Dabur India Ltd., Sahibabad, Ghaziabad, Uttar Pradesh, India. Author
  • P P Raturi Head, Department of Bio-resources, Dabur Research and Development Centre, Dabur India Ltd., Ghaziabad, Uttar Pradesh, India. Author
  • R K Rai Head, Healthcare, Dabur Research and Development Centre, Dabur India Ltd., Ghaziabad, Uttar Pradesh, India. Author

DOI:

https://doi.org/10.48165/IRJAY.2023.6801

Keywords:

Alternatives, Ayurveda, Conservation, Phytoconstituents, Raw Drugs, Taxonomy

Abstract

 

Introduction: Natural habitats of the medicinal and aromatic plants (MAPs) are declining due to unsustainable  collection, high demand, and high volume and continuous supply of the raw materials, and most recently due to  global and regional climatic changes. Hence, there is a high need to alternate the original species in terms of plants  and plant part use. Materials and Methods: Alternatives/substitution of an Ayurvedic, genuine, and grantha based, as per Ayurvedic  Pharmacopoeia of India species are studied and analyzed with taxonomical and phytochemicals points of view such  as Rasa, Guna, Veerya, Vipaka, and Prabhava versus species, genus, family, and order along with bioactive chemical  markers.  Results and Discussion: Some of the RET, MAPs are belong to monotypic genus and some are also belong to IUCN  red list category: Aconitum chasmanthum Stapf. ex Holmes, Aegle marmelos L., Aquilaria agallocha Roxb., Berberis  aristata DC., Cissampelos pareira L., Commiphora wightii (Arnott) Bhandari, Embelia ribes (Burm.) F., Gmelina  arborea Roxb., Hemidesmus indicus (L.) R. Br., Hydnocarpus kurzii (King) Warb, Nardostachys grandiflora Wall.  ex DC., Oroxylum indicum (L.) Kurz, Picrorhiza kurrooa Royle, Pterocarpus santalinus L. f., Saraca asoca (Roxb.)  Wild, Stereospermum suaveolens (Roxb.) DC, Swertia chirayita (Roxb. ex Flem.) Karst and Tecomella undulata (Sm.) Seems has been suggested for possible alternates with the plants and plant part use. Selection of substitution  may be regional or disease-wise in particular but in general whole plants substitution required comprehensive study  on botanical aspects, active phytoconstituents, biological active markers, and pharmacological activity.

Downloads

Download data is not yet available.

References

Tiwari R, Rana CS. Plant secondary metabolism: A review. Int J Eng Res Gen Sci 2015;3:661-70.

Schippmann U, Leaman DJ, Cunningham AB. Impact of Cultivation and Gathering of Medicinal Plants on Biodiversity: Global Trends and Issues. Frontis. Italy: Food and Agriculture Organization; 2006. p. 75-95.

Goraya GS, Ved DK. Medicinal Plants in India: An Assessment of their Demand and Supply. Dehradun: National Medicinal Plants Board, Ministry of AYUSH, Government of India, New Delhi and Indian Council of Forestry Research and Education; 2017.

Rana CS, Kimothi GP. Climate Change, Cultivation Practices, and Mitigation in the Present Scenario. Climate Change and Environmental Issues. Bengaluru: The Energy and Resources Institute (TERI); 2016. p. 29-38.

Rana CS, Negi YS, Sawant LP, Raturi PP. Commercial cultivation and sustainability of Pushkarmool (Inula racemosa), a case study from Keylong, Lahaul & Spiti, Himachal Pradesh, India. J Mt Res 2022;17:25-33.

Kumar P. Adulteration and substitution in endangered, ASU herbal medicinal plants of India, their legal status, scientific screening of active phytochemical constituents. Int J Pharm Sci Res 2014;5:4023-39.

Rawat DS, Chandra S, Chaturvedi P. Threatened flora of Uttarakhand: An update. J Threatened Taxa 2022;14:22309-28.

Rathore P, Bhagat S. Substitution in Ayurveda W.S.R to Yogratnakar, a conceptual study. Int Res J Ayurveda Yoga 2022;5:165-71. 9. Gupta AK. Quality Standards of Indian Medicinal Plants. New Delhi: ICMR; 2003.

Keshari P, Pradeep. Controversy, adulteration and substitution burning problems in ayurveda practices. Int Ayurvedic Med J 2017;5:2501-16.

Sreelekshmi M, Vimla KS, Paul RP, Chandran N, Shine PA, Salam NA. Drug adulteration: A threat to efficacy of Ayurveda medicine. J Med Plant Stud 2017;5:1-6.

Shetty M. Yogaratnakara. Purvardha, Abhavavarga/38. Edited and Translated 1st ed. Varanasi: Chowkhambha Sanskrit Series; 2005. p. 178.

Garg S. Introduction, Substitute and Adulterant Plants. Delhi: Periodical Experts Book Agency; 1992.

Saraswathy A. Adulterants and substitutes in ayurveda. Sachitra Ayurveda 2001;54:63-6.

Mitra SK, Kannan RA. Note on unintentional adulterations in ayurvedic herbs. Ethnobotanical Leaflets 2007;11:11-5.

Poornima B. Adulteration and substitution in herbal drugs. A critical analysis. Int J Res Ayurveda Pharm 2010;1:8-12.

Prakash O, Jyoti AK, Kumar P, Kumar NK. Adulteration and substitution in Indian medicinal plants: An overview. J Med Plants Stud 2013;4:127-32.

(substitute drugs) in ayurveda. Pharmagene 2013;1:85-8. 19. Poonam. Adulteration of crude drugs burning problem. Int J Appl Res 2016;2:99-101.

Prachi AK, Prashant B, Nandwate. Substitutes for Ayurvedic medicinal herbs: A review. Int J Rec Fut Ayurveda Sci 2017;2:107-14. 21. Shinde A, Gahunge P, Rath S. The real concept of substitution in Ayurveda literature and adulteration the misleading concept of modern era. J Ayurveda Int Med Sci 2018;3:149-58.

Manisha, Sharma O, Garg NK. Relevance and impact of pratinidhi dravyas in chikitsa: Areview article. World J Pharm Res 2021;10:515-20. 23. Sharma PV. Dravya-Guna Vigyan. Varanasi: Chaukhambha Bharati Academy; 2014.

Rana CS, Raturi PP, Rai RK. Notes on ayurvedic alternates following plant taxonomy. J Mt Res 2023;18:11-22.

Rana CS, Raturi PP, Rai RK. Microscopy of Ashoka Bark and marketed alternates. Int Res J Ayurveda Yoga 2023;6:111-8. 26. Mao AA, Dash SS. Flowering Plants of India, an Annotated Checklist. Vol. 1-3. Kolkata: Botanical Survey of India; 2020.

Mabberley DJ. Mabberley’s Plant Book. 4th ed. Cambridge: Cambridge University Press; 2017. p. 1102.

BSI. Checklist of Plants of India; 2023. Available from: https:// efloraindia.bsi.gov.in/action [Last accessed on 2023 Jul 27]. 29. Dubey NK, Kumar R, Tripathi P. Global promotion of herbal medicine: India’s opportunity. Curr Sci 2004;86:37-41.

Sarin YK. Illustrated Manual of Herbal Drugs used in Ayurveda. Delhi: CSIR and ICMR; 1996.

Rana CS, Sharma A, Kumar N, Dangwal LR, Tiwari JK. Ethnopharmacology, Indigenous collection of some important medicinal plants of Niti Valley in Nanda Devi National Park, Uttarakhand, India. Nat Sci 2010;8:9-14.

Jadav HR, Ruknuddin G, Harisha CR, Kumar PP. Preliminary pharmacognostical profile of tuvaraka (Hydnocarpus laurifolia (Dennst) Sleummer.) seeds. Med J DY Patil Univ 2016;9:219-23.

Kaushik P, Ahlawat P, Singh K. Chemical constituents, pharmacological activities, and uses of common Ayurvedic medicinal plants: A future source of new drugs. Adv Tradit Med 2021; https:// doi.org/10.1007/s13596-021-00621-3.

Kumar P, Nishteswar AK. Phyto-chemical and pharmacological profiles of Clerodendrum serratum Linn. (Bharngi): A review. Int J Res Ayurveda Pharm 2013;4:276-8.

Kumbhar AD, Naikare SS. Medicinal plant review: Bharangi (Clerodendrum serratum). Int J Creat Res Thoughts 2018;6:372-6. 36. Wang S, Yu Z, Wang C, Wu C, Guo P, Wei J. Chemical constituents and pharmacologi

Downloads

Published

2023-08-31

How to Cite

Rana, C. S., Raturi, P. P., & Rai, R. K. (2023). Alternates of the Medicinal and Aromatic Plants for Future Industrial Demand, Development, and Conceivable Conservation . International Research Journal of Ayurveda & Yoga, 6(8), 1-8. https://doi.org/10.48165/IRJAY.2023.6801